MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

27th-Jun-2012 15:30Source: BSE

Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Nithyananda Reddy has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

More Announcements on:

20th-May-2013 11:10Source: BSE

Aurobindo Pharm - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

17th-May-2013 12:22Source: BSE

Aurobindo Pharm - FY13 results on May 30, 2013

6th-May-2013 09:36Source: NSE

Aurobindo Pharma Limited Press Release

4th-May-2013 15:26Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives USFDA Approvals for Tamsulosin HCL Capsules and Clindamycin Palmitate Hydrochloride for Oral Solution (Pediatric)

30th-Apr-2013 13:39Source: NSE

Aurobindo Pharma Limited

30th-Apr-2013 13:21Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives USFDA Approval for Quinapril Tablets

26th-Apr-2013 14:49Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives USFDA Approval for Cefadroxil Oral Suspension

26th-Apr-2013 13:31Source: NSE

Aurobindo Pharma Limited

3rd-Apr-2013 12:27Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives tentative approval for Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Tablets

3rd-Apr-2013 11:41Source: NSE

Aurobindo Pharma Limited

1 2 3 4 5 Next >>
Board Meeting (Aurobindo Pharm)

Meeting Date

Remark

2013-05-30

Audited Results & Final Dividend

Add to Watchist
close[x]
Have you invested in these stocks? You can track them better in your Portfolio
Edit Watchlist
Just Dial IPO opens for subscription today with a price range of Rs. 470 - 543. Is Just Dial IPO rightly priced?
Yes
No

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window